Company files certificate for new Series B preferred stock
Allarity Therapeutics filed a certificate of designation for Series B preferred stock, which was authorized by the Board of Directors on November 12, 2026. No shares of the Series B have been issued as of the filing.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed